Ampio Pharmaceuticals, Inc. (NASDAQ: AMPE) Extended Trial Shows Patients Can Avoid Total Knee Replacement

AMPE has made it known that they are up for sale and if someone doesn’t buy or license the technology soon, they have the capability to proceed on their own.

Ampio Pharmaceuticals, Inc. (NASDAQ:AMPE)

AMPE has made it known that they are up for sale and if someone doesn’t buy or license the technology soon, they have the capability to proceed on their own.”

— Ampio Pharmaceuticals (NASDAQ: AMPE)

MIAMI, FLORIDA, USA, March 30, 2018 /EINPresswire.com/ — (EmergingGrowth.com NewsWire) — EmergingGrowth.com, a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth markets and companies, reports on Ampio Pharmaceuticals, Inc. (NASDAQ: AMPE)

View the complete article including the valuation gap and Investment summary with price target here: http://emerginggrowth.com/ampio-pharmaceuticals-inc-nasdaq-ampe-extended-trial-shows-patients-can-avoid-total-knee-replacement/

STRUT extended trial Results Show Reduction in TKR Surgeries
Possible First Line Therapy Designation
Likelihood of Approval Moves Forward
Big Pharma Opioid Manufacturers and OAK Drug Companies – Ideal Suitors
Risk Adjusted Earnings Model Supports Hefty $5 Billion + Valuation
Ampio Pharmaceuticals, Inc. (AMPE) announced extended clinical trial results from the STRUT study that showed use of AmpionTM lowered the rate of Total Knee Replacement (TKR) surgery by almost 50% over the use of Saline. Although this study was preliminary in nature it’s results were statistically relevant which means that when the study is completed there is a very high likelihood the outcome will be the same on the larger subset of people.

The impact of these results mean that AMPE can add to the list of current drug uses such as reducing pain, reducing inflammation, increasing function, and increasing global assessment. In addition, the company will be able to claim that the drug reduces TKR’s. This is a complete paradigm shift in the treatment of Osteoarthritis of the Knee (OAK) because now it’s viewed as a Disease Modifying Therapy (DMT). Top drug makers for OAK like Johnson and Johnson (NYSE: JNJ), Pfizer (NYSE: PFE), Teva Pharmaceuticals (NYSE: TEVA), and Purdue focus on reducing pain in this patient population through the use of opiates. Another tier of drug companies which include names like Sanofi Adventis (NYSE: SNY) and Flexion (NASDAQ: FLXN) have focused corticosteroids and hyaluronic acid. AmpionTM is a biologic which means it’s synthesized from human proteins and has no addictive properties like opiates and can be used over and over again.

At the completion of this trial AMPE can include in their Biologics License Application (BLA) that use of AmpionTM will reduce the need for a TKR and up to 5 injections MUST be given before a TKR can be performed. The significance of this paradigm shift is that Orthopedic Surgeons will be required to give AmpionTM before a TKR is performed. The assumption that a large sales force will be needed to sell this drug is no longer valid for a DMT that becomes the new standard of care (SOC).

Trial Results

The STRUT study was a randomized, saline vehicle-controlled study to evaluate the safety and efficacy of AmpionTM when administered as three 4 ml inter articular (IA) injections delivered every two weeks. The study involved a total of 47 patients which was done in 2 phases. Phase 1 was a 7 patient single blind phase where all patients received AmpionTM. Phase 2 was randomized on a 1:1 basis with AmpionTM vs Saline. The primary endpoint was change in WOMAC pain between baseline and week 20. Using an IRB approved protocol AMPE followed up with 39 of 45 patients that completed the study 3.5 years later using a telephone questionnaire. The number of severe or KL-4 patients that would need a TKR was 16.

View the chart here: http://emerginggrowth.com/wp-content/uploads/2018/03/AMPE-Pic-1.png

What this chart shows is a statistically significant change in the number of TKR’s performed when using AmpionTM. Using the most conservative results AmpionTM can reduce the number of TKR surgeries by close to 50%. If you combine the two groups the numbers are even more impressive with a 29.4% likelihood of a TKR vs an 83.3% using saline. Keep in mind this data point is 3.5 years after injection. This is the most compelling data ever presented in OAK and KL-4 patients and represents a DMT that should be the new SOC and first-line therapy.

Effect on Orthopedic Landscape – First-Line Treatment Designation

Right now the orthopedic market does conservatively 640,000 TKR’s per year. AMPE is seeking a label for up to 5 injections of AmpionTM as needed. Orthopedic surgeons might have had the opportunity to make a judgement call on performing a TKR surgery instead of using AmpionTM. The release of this new this new data statistically shows that AmpionTM should be the first-line treatment in KL-4 patients before attempting a TKR. Ultimately the FDA makes the decisions on this matter but standard governmental guidelines reveals that any first-line treatment that shows an improvement of 30% over the existing standard of care would likely get the first-line treatment designation. Should AMPE get first-line treatment designation, orthopedic surgeons would be required to use AmpionTM before attempting a TKR. This labeling designation could give AMPE the TKR market on a silver platter.

When doctors see the effect of the drug on the most diseased patients, which is measured in weeks, it’s not hard to envision that use of the drug would be prescribed on less severe indications in place of prescribing opiates, corticosteroids and hyaluronic acid. Since doctors see patients at all stages of disease progression, this could be a real multiplier effect driving off label use of the drug.

OAK Drug Development Pipeline

There are 3 types of treatment options for KL-4 patients which include Hyaluronic Acid, Corticosteriods, and Opioids. All these existing treatment options depicted in the chart below fell short in clinical trials in reducing pain and increasing functional improvement but the story doesn’t end there. Two major reports written by the Journal of American Medical Association (JAMA) and the American Academy of Orthopedic Surgeons (AAOS) which both state they “do not support use of triamcinolone’”, “we cannot recommend using hyaluronic acid.” With the exception of AmpionTM, all these drugs in the chart below are FDA approved in this indication even though they missed their endpoint in clinical trials. It’s clear that two nationally recognized associations believe that none of these drugs work and a solution is needed. If approved, AmpionTM will be the only drug that actually met its endpoints.

View the chart here: http://emerginggrowth.com/wp-content/uploads/2018/03/AMPE-Picture-2.png

Major pharmaceuticals like Sanofi Adventis (NYSe: SNY), Johnson and Johnson (NYSE: JNJ), and Flexion (NASDAQ: FLXN) have failed to meet their endpoints in OAK but got marketing approval because there really aren’t any good options for patients until the advent of AMPE. None of these drugs work effectively long term and have proven to accelerate the disease progression. Injections do work for a short period but the mechanism of action is essentially taking a thin layer of cartilage and liquefying it to provide temporary relief. This isn’t a good long term solution. It is for this lack of a solution that state reimbursements are drying up for the top drug manufacturers. Another solution is needed and AMPE seems to have it.

View the data here: http://emerginggrowth.com/wp-content/uploads/2018/03/AMPE-3.png

AMPE – Excellent Buyout Candidate for Big Pharma

Current opiate pharmaceutical manufacturers like Johnson and Johnson (NYSE: JNJ), Pfizer (NYSE: PFE), and Teva Pharmaceuticals (NYSE: TEVA) have come under major political scrutiny for their role in creating the opioid epidemic. Last month Trump announced $13 billion to combat the opioid crisis. Big opiate manufacturers like Johnson and Johnson (NYSE: JNJ) are likely to view the purchase of AMPE as not only good publicity but also has the upside of owning a platform technology. Many of these companies if not all were at the JP Morgan (NYSE: JPM) Conference in January and could be in the process of submitting bids to buy AMPE because it would fix the existing political situation and fill the hole left by the drop in sales they have experienced from the inability to market their drugs.

Investors might find that Merck (NYSE: MRK) is also an interesting suitor because it has not voiced plans to pursue its FORWARD trial which it completed in November 2017. MRK has made overtures that the Osteoarthritis Market needed disease modifying modalities that slow or reverse the progression of the disease. In an earlier release of data in the STRUT trial, AmpionTM demonstrated clinically significant cartilage growth of .02mm in as little as 3 months with one injection compared to MRK’s drug Sprifermin which had the same .02mm growth in healthier knees but took 2 years to get to that level.

Likelihood of Marketing Approval

With 1 pivotal trial completed and another phase 3 trial that exceeded the endpoints the BLA has met the prerequisite requirements defined by the FDA AMPE can look forward to the labeling of the drug and eventually approval. The company has indicated on the latest conference call that they have enough money to complete the BLA and expect to have it done by Q3 if not sooner. It was also included as part of their budgeted burn rate which means they are working on it now. There are some great statistics in the pharmaceutical industry that break down the Likelihood of Approval (LOA) and the next milestone for this company is submitting the BLA license. Assuming they have the BLA done and have submitted the file to the FDA, investors can anticipate the probability of approval is 88.4% according to the Biotech Innovation Organization. The market should start factoring this probability into the stock price as time progresses but might need a catalyst.

Valuation and Market Disconnect

At times the market can be very inefficient at price discovery which could lead to huge swoons and falls in price in the presence of a catalyst. In the case of AMPE, the market disconnect from true valuation is more pronounced so it’s important to look at what factors are impeding true price discovery.

The first factor is the markets fear of further dilution. The company did a couple of rounds of what was viewed as dilutive financing. The company stated on the last conference call that they had $11.2 million in cash, access to a credit facility, and over 5 million warrants in the money that have not yet been exercised. This translates into an $830,000 monthly burn rate with enough cash to take them through January 2019.

The next factor deals with AMPE’s ability to get a licensing deal. The market is simply impatient and feels that if the drug is as good as claimed it shouldn’t take so long to get a licensing deal. The absence of a licensing deal announcement has put considerable pressure on the stock. Adding to the pressure is very high level of short interest in the stock with 13.1% of the float short. The stock is number 18 on the largest short position list. There are also “Fake News” reports weighing heavily on the stock price suggesting that AmpionTM is no better than saline playing on investor’s fears that drug approval is not likely. This negative sentiment is weighing heavily on stock price and the catalyst that could break this deadlock is a licensing deal as it puts to rest the issue of dilution and the ability to generate meaningful revenue.

View the risk adjusted NPV worksheet here: http://emerginggrowth.com/wp-content/uploads/2018/03/AMPE-4.png

Net Present Value Model vs Appraisal

The net present value model risk adjusted is a summation of all the future earnings streams and discounted into today’s dollars. Valuations balloon in this model using even the most conservative numbers. Readers should notice the model uses a 9% probability of approval, which is typically the baseline for a New Drug Application (NDA). The profit per dose of $200 is based off the current retail price of Hyaluronic acid which ranges from $300 – $750 per injection. According to AMPE, the label will stipulate up to 5 injections per year which places the profit per patient at $1000 per year. The current risk adjusted model places a $9.533 billion valuation on AMPE using these assumption.

The probability of approval number should be 88.4% and if used in the model with ONLY KL-4 patients yields a risk adjusted value of $6.524 billion.

Although no valuation report was made public, methodology would be the same and include more indication as this model does but with one major caveat. In all likelihood the model DID NOT include 100% market share of the KL-4 patients because that data was just released and the company had indicated the valuation was completed and in the 10 digits.

This last trial data release was a major game changer in valuation because instead of having to build a sales force to achieve market penetration AMPE gets it on day 1 as this is likely to be a mandated first line therapy. Orthopedic surgeons should have no choice but to try it before they can do surgery.

The model is extremely conservative and allows investors to throw out the opiate abusers and other joint surgeries and still and get a valuation in the billions. CEO Macaluso said an appraisal was done with figures in the “ten digit area” and expects the new appraisal with the expanded label will be “multiples” of that. This means the company has gone on record with a $2 billion plus appraisal yet the market capitalization sits at $200 million roughly 10% of its potential value according to the Company.

View the complete article including the valuation gap and Investment summary with price target here: http://emerginggrowth.com/ampio-pharmaceuticals-inc-nasdaq-ampe-extended-trial-shows-patients-can-avoid-total-knee-replacement/

About EmergingGrowth.com

EmergingGrowth.com is a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth markets and companies. Through its evolution, EmergingGrowth.com found a niche in identifying companies that can be overlooked by the markets due to, among other reasons, trading price or market capitalization. We look for strong management, innovation, strategy, execution, and the overall potential for long- term growth. Aside from being a trusted resource for the Emerging Growth info-seekers, we are well known for discovering undervalued companies and bringing them to the attention of the investment community. Through our parent Company, we also have the ability to facilitate road shows to present your products and services to the most influential investment banks in the space.

All information contained herein as well as on the EmergingGrowth.com website is obtained from sources believed to be reliable but not guaranteed to be accurate or all-inclusive. All material is for informational purposes only, is only the opinion of EmergingGrowth.com and should not be construed as an offer or solicitation to buy or sell securities. The information may include certain forward-looking statements, which may be affected by unforeseen circumstances and / or certain risks. EmergingGrowth.com has not been compensated by, any company mentioned in this article. Please read our full disclosure, which can be found here, http://emerginggrowth.com/disclosure/. Please consult an investment professional before investing in anything viewed within this article or any other portion of EmergingGrowth.com. In addition, please make sure you read and understand the Terms of Use, Privacy Policy and the Disclosure posted on the EmergingGrowth.com website.

Emerging Growth Staff
EmergingGrowth.com
305-330-1985
email us here


Source: EIN Presswire

Blockchain Technology Market Size, Country Outlook, Growth Potential, Competitive Strategies And Forecasts 2018 To 2023

Wiseguyreports.Com Adds “Blockchain Technology -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2022” To Its Research Database

PUNE, MAHARASHTRA, INDIA, March 30, 2018 /EINPresswire.com/ — Blockchain Technology Industry

Description

The application of blockchain has now shifted to various areas such as payments, exchanges, smart contracts, digital identity, documentation, clearing, and settlement. Some of the major factors driving the growth of the blockchain technology market are transparency and immutability, faster transactions, and reduced total cost of ownership. The blockchain technology also offers other key benefits such as trustless exchange, durability and reliability, and empowers the users to control all their information and transactions. In coming years the key opportunity areas for blockchain technology would be disruption in technology across various industries; high adoption of blockchain technology for payments, smart contracts and digital identities; and evolution of a new breed of programmable blockchain technology platforms. Blockchain is a distributed ledger technology that records the cryptocurrency transaction data into blocks. Each time a block gets completed, a new block is generated; the blocks are linked to each other in proper linear, chronological order like a chain, with every block containing a hash of the previous block. Each block containing the data is cryptographically hashed, using complex mathematical algorithms.

Request for Sample Report @ https://www.wiseguyreports.com/sample-request/1566115-global-blockchain-technology-market-2017-2027-by-type-private-public-hybrid

In 2008, cryptocurrency was used by gamers and traders for gambling purposes. The blockchain concept gained popularity in 2009 and was implemented into the source code for bitcoin, with the goal of overcoming the shortcomings of physical commodities such as currency. This created a global means of value exchange that was reliable as well as secure, and was used by different intermediaries to conduct and settle transactions. As the distributed ledger technology gained momentum, various use cases of the blockchain technology were explored. In 2016, the blockchain technology went mainstream.

The scope of this report covers the blockchain technology market by type, solution provider, application, end-use industry, and region. The Banking, Financial Services, and Insurance (BFSI) sector is expected to dominate the market during the forecast period, whereas the media and entertainment vertical is estimated to grow at the highest rate, followed by the healthcare and life sciences vertical. The need for banking and financial transactions that are seamlessly integrated into a new and always connected lifestyle will result in the payments market accounting for the largest share during the forecast period. The digital identity market is expected to grow at the highest rate, as blockchain technology will make digital identities more secure and efficient, resulting in seamless sign-on, and also reduce identity frauds by enabling the user identity to be uniquely authenticated in an immutable and secure manner.

North America is expected to hold the largest share of the blockchain technology market during the forecast period, due to the early adoption of blockchain technology in the banking and financial services vertical. APAC offers potential growth opportunities for the blockchain technology market as financial technology investments in distributed ledger technology are expected to grow in the next ten years.

Key innovators in the blockchain technology market include IBM Corporation, Microsoft Corporation, Deloitte, Ripple, Chain, Abra, BitFury, Coinbase, Circle, Digital Asset Holdings, Blockchain Tech Ltd., Global Arena Holding, Inc. (GAHI), Digital CC Ltd., 21, Inc., and Earthport. These players adopted various strategies such as venture capital funding, new product developments, mergers, partnerships, collaborations, and business expansions to cater to the needs of the global blockchain technology market.

For example, IBM Corporation recently launched cloud services for blockchain on Linux-only secure server; and Deloitte, entered into a partnership with Terepac Corporation, a company dealing with IOT devices and data, to create a distributed ledger to allow manufacturers to follow the entire life-cycle of their products, as part of Internet of Things (IOT).

Leave a Query @ https://www.wiseguyreports.com/enquiry/1566115-global-blockchain-technology-market-2017-2027-by-type-private-public-hybrid

Table of Content

1. EXECUTIVE SUMMARY
2. GLOBAL SCENARIO
1. GLOBAL MARKET FOR BLOCKCHAIN TECHNOLOGY
2. MARKET DYNAMICS
1. DRIVERS
2. RESTRAINTS
3. CHALLENGES
3. KEY OPPORTUNITY: IoT IN MANUFACTURING APPLICATIONS

3. TECHNO-ECONOMIC ANALYSIS
1. GLOBAL BLOCKCHAIN TECHNOLOGY MARKET

4. MARKET SEGMENTATIONS
1. BLOCKCHAIN TECHNOLOGY MARKET BY TYPE
1. PUBLIC
2. PRIVATE
3. HYBRID
2. BLOCKCHAIN TECHNOLOGY MARKET BY SOLUTION PROVIDER
1. PROFESSIONAL SERVICES
2. MANAFGED SERVICES
3. BLOCKCHAIN TECHNOLOGY MARKET BY PLATFORM
1. APPLICATION AND SOLUTION PROVIDER
2. MIDDLEWARE PROVIDER
3. INFRASTRUCTURE AND PROTOCOLS PROVIDER
4. BLOCKCHAIN TECHNOLOGY MARKET BY APPLICATION
1. PAYMENTS
2. EXCHANGES
3. INTERNET OF THINGS (IoT)
4. SMART CONTRACTS
5. DOCUMENTATION
6. DIGITAL IDENTITY
7. OTHERS
5. BLOCKCHAIN TECHNOLOGY MARKET BY CONNECTIVITY
1. BFSI
2. GOVERNMENT AND PUBLIC SECTOR
3. HEALTHCARE
4. RETAIL AND E-COMMERCE
5. AUTOMOTIVE
6. MEDIA AND ENTERTAINMENT
7. OTHERS

5. MARKET BY GEOGRAPHY
1. NORTH AMERICA
1. U.S.
2. CANADA
3. MEXICO
2. EUROPE
1. U.K.
2. GERMANY
3. FRANCE
4. AUSTRALASIA
5. CHINA.
6. JAPAN
7. SOUTH KOREA
8. INDIA
3. SIGNIFICANT REST OF WORLD
1. MIDDLE EAST & AFRICA
2. LATIN AMERICA

6. COMPETITOR INTELLIGENCE
1. MARKET SHARE ANALYSIS
2. MAJOR START-UPS EXISTING IN BLOCKCHAIN TECHNOLOGY MARKET AND RELATED DOMAINS
3. MANUFACTURERS AND PRIMARY STAKEHOLDERS IN THE MARKET

7. COMPANY PROFILES
1. MICROSOFT CORPORATION
2. IBM CORPORATION
3. DELOITTE
4. RIPPLE
5. CHAIN, INC.
6. BTL GROUP
7. GROUP ARENA HOLDING, INC.
8. DIGITALX, LTD.
9. EARTHPORT
10. ABRA INC.

8. APPENDIX
1. SCOPE
2. RESEARCH METHODOLOGY
3. ASSUMPTIONS
4. VALUE-CHAIN ANALYSIS
5. LIST OF TABLES AND FIGURES IN THE REPORT

Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=1566115

Continued…           

Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (Us)  Ph: +44 208 133 9349 (Uk)

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Industrial Robotics Market 2018 Global Trend, Segmentation and Opportunities Forecast To 2024

Wiseguyreports.Com Adds “Industrial Robotics -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2022” To Its Research Database

PUNE, MAHARASHTRA, INDIA, March 30, 2018 /EINPresswire.com/ — Industrial Robotics Industry

Description

Industrial robots have been termed a disruptive technology that will change the future course of both the manufacturing and non-manufacturing industries. An industrial robot is a multipurpose manipulator that can be reprogrammed in three or more axes to complete tasks.

Far from being a data collection resource, this report strategically analyses the industrial robotics market on multiple levels which include both macro factors and micro factors affecting segmental markets. Whilst measuring the competency of any market, the core factors that play a part in complete understanding of the market like the value chain analysis, techno-economic analysis, key opportunities for the future, and so on are discussed in detail in the report. The use of infographics to simplify and better represent large amounts of data also reinforces our strong belief in efficiency and outcome-prediction focused market research.

Industrial robotics is one of the key automation technologies that is changing the way industries function by eliminating the need for humans involved in repetitive and tedious tasks. Robots function at the same level of efficiency for prolonged periods of time at great speed and with high accuracy. Add to this, one of the major problems faced by the industry, regardless of the domain; the constant increase in labor costs across geographies and industrial sectors, and industrial robots are likely to be the best solution.

Request for Sample Report @ https://www.wiseguyreports.com/sample-request/1413334-the-global-industrial-robotics-market-2015-2024-complete-market-research-study

The report segments the market based on the following factors:

Applications- Scope of the report includes all manufacturing and non-manufacturing sectors where industrial robotics is currently being used in. This includes the Automotive industry, Electrical and electronics industry, Metal and machinery industry, Rubber, Plastics and chemicals industry, Food and beverages industry, Glass and Ceramics, Paper, Printing and Publishing, Lumber and Wood Products, Fibers, Apparel and Leather under the manufacturing sector. The non-manufacturing sector includes Entertainment, Education, and Research and Development, Construction, Agriculture, Forestry and Fishing, Electricity, Gas and Water supply, the Mining Industry (Digging and Quarrying).
Other manufacturing sectors and non-manufacturing sectors have been included in the ‘others’ segment. Robotics in the oil & gas sector has also been grouped under others.

Industrial Robots by Usage- This section segments the industrial robot market on the basis of the different functional usages that industrial robots are most commonly used for. This includes robots sold to industries for material handling operations, welding & soldering operations, dispensing, processing operations and assembly and disassembly. All other usages of industrial robots like those used for clean room operations in the semiconductor industry and other operations across the manufacturing and non-manufacturing sectors have been grouped under ‘others’.

Industrial Robots by Type- The market has been classified on the basis of robot types as follows: Articulated Robots, Cartesian Robots, Cylindrical robots SCARA robots and others. The others segment includes polar robots, delta robots and other use-case robot configurations.

A top-down approach to the market alone is not sufficient to correctly estimate the current market. Thus a detailed bottom-up approach from the perspective of the players in the market was also done. This led to a comprehensive analysis on the competitive landscape of players existing in this market. The market share revenue analysis shows the shares of each player in the market currently (2014) and historically over the last 3 years.

The geographical analysis is one of the key segments of the report. It details the current state, macro and micro factors, Governmental policies, and future trends of the industrial robotics market in 19 major geographies across 4 regional segments namely, The Americas, Europe, Australasia and the rest of the world.

The report also talks about the state of the upcoming start-up companies in the industrial robotics market and looks at the technological roadmap for the future and newer application sectors. The company round-up section gives an overview of the strategies and financials of the key players in the market.

Leave a Query @ https://www.wiseguyreports.com/enquiry/1413334-the-global-industrial-robotics-market-2015-2024-complete-market-research-study

Table of Content

1. EXECUTIVE SUMMARY
1.1. KEY POLICY ISSUES AND RECOMMENDATIONS FOR THE INDUSTRIAL ROBOTICS MARKET
1.2. EXECUTIVE SUMMARY INFOGRAPHIC
1.2.1. GLOBAL MARKET MACRO TRENDS
1.2.2. FUTURE OUTLOOK
2. SCOPE, METHODOLOGY & ASSUMPTIONS
3. GLOBAL SCENARIO
3.1. GLOBAL SCENARIO
3.1.1. GLOBAL MARKET FOR INDUSTRIAL ROBOTICS AND FUTURE DEMAND
3.1.2. MARKET VOLUME (SHIPMENTS)
3.1.3. MARKET REVENUE
3.1.4. AVERAGE SELLING PRICE
3.1.5. YEAR-ON-YEAR GROWTH OF SHIPMENTS
3.1.2. SOFTWARE AND SERVICES MARKET
3.1.2.1. MARKET TRENDS
3.1.8. VALUE CHAIN ANALYSIS
3.1.9. KEY OPPORTUNITY: INDUSTRIAL ROBOTICS IN SMALL AND MEDIUM ENTERPRISES (SMES)
3.1.10. SAFETY FACTORS FOR ROBOTS USE IN SMES
3.1.11. THE RISE OF THE CO-BOTS
3.1.12. TECHNO-ECONOMIC ANALYSIS
3.1.13. COMPETITOR INTELLIGENCE

6. START-UP SCENARIO
6.1. UNDERWATER EXPLORATION
6.2. MATERIAL HANDLING
6.3. ARTIFICIAL INTELLIGENCE
6.4. AGRICULTURE
7. COMPANY ROUND-UP
7.1. YASKAWA ELECTRIC CORPORATION (JAPAN)
7.2. ABB ROBOTICS (SWITZERLAND)
7.3. FANUC CORPORATION (JAPAN)
7.4. KUKA AG (GERMANY)
7.5. KAWASAKI HEAVY INDUSTRIES LIMITED (JAPAN)
7.6. EPSON ROBOTS – SEIKO EPSON (JAPAN)
7.7. NACHI-FUJIKOSHI CORP. (JAPAN)
7.8. ADEPT, INC. (U.S.)
8. ANALYST IMPACT CENTER (AIC)
9. APPENDIX

Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=1413334

Continued…

Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (Us) Ph: +44 208 133 9349 (Uk)

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Debit cards with transactions share close to 82% lead the Singapore Cards and Payments Market

Singapore Credit Card Market Share Analysis by Issuer | MarketDataForecast

Singapore Cards And Payments Market – Transaction Value, Volumes, Historical Trends, Analysis And Forecasts (2017 -2021)

The market trends with all types of payment options like debit card, online transfers and cash on delivery, which are expected to double their current growth from 9% as per WorldPay.”

— Market Data Forecast

HYDERABAD, TELANGAANA, INDIA, March 30, 2018 /EINPresswire.com/ — Market Data Forecast – Recent Report – Singapore Cards and Payments Market – By Cards (Debit Cards, Credit Cards, Prepaid Cards), By Payment Terminals (POS and ATM's), By Payment Instruments (Credit Transfers, Direct Debit, Cheques and Payment Cards) – Transaction Value, Volumes, Historical Trends, Analysis and Forecasts (2017 -2021)

Singapore debit cards are primarily divided into PIN-based cards and signature-based cards. Visa and MasterCard are considered under signature-based and NETS EFTPOS under PIN-based debit cards. In terms of transaction values, debit cards hold the principal share around 82% of the total volume in 2015 with the three leading card issuers accounting close to 94% of the total debit cards payments. In June 2010, a new PIN-based card system called EPINS was launched by Card Alliance Private Limited in Singapore markets. Currently, these EPINS payments are accepted by all major retailers that include Giant hypermarkets, Singapore Post and Court, selected 7-Eleven Stores, Marketplace supermarkets, Shop N Save, Cold storages and others.

Explore more details about the Singapore Cards and Payments Market Report @ https://www.marketdataforecast.com/market-reports/Singapore-Cards-and-Payments-Market-6849/

Multiple Payment Options Drive The Singapore Cards And Payments Market

The Singapore Cards and Payments Market penetration for the debit cards is around 2 cards per individual in Singapore. Since customers prefer debit card purchases rather than pay later cards, the banks and card issuers are concentrating on providing various categories of debit cards based on the customer’s choice using micro-segmentation. Some banks like DBS also offer free cards without any annual charges to lure its customers.

The electronic payment provider designed by the MAS, NETS dominated the debit cards market with close to 75% of the total cards in circulation and their transactions. NETS cards are offered by all leading banks and they are accepted at almost all the retail stores of Singapore. They are offered in chip and PIN technology with the aid of banks like UOB, OCBC, and Maybank.

DBS bank accounts for the highest debit card transactions followed by UOB Bank. The increasing expansion of traditional and pop-up ATMs by DBS bank and specific customer targeted debit cards has supported the payment cards usage of customers in Singapore. UOB has introduced contactless debit cards in 2014 and provides special business debit cards for small business enterprises that offer various reward points to the customers.

The innovative features like contactless payments and reward points or cash backs associated with the use of debit cards are primarily increasing the growth of debit cards in Singapore markets. The rapid growth in e-commerce and retail industry, electronic payments in tourism, government initiatives like the installment of contactless POS terminals under the iN2015 Next Generation e-Payment Program also supports the Singapore Cards and Payments Market expansion. Although many retailers accept card payments, people are using debit cards for ATM withdrawals compared to POS terminal transactions.

Get Sample of Report @ https://www.marketdataforecast.com/market-reports/Singapore-Cards-and-Payments-Market-6849/request-sample

About Market Data Forecast:
Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extensive research.

Contact Us:
Abhishek Shukla
Sales Manager
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com

Sai Kutumbarao
Market Data Forecast
7680952236
email us here


Source: EIN Presswire

AXA Insurance Market 2018 Industry Analysis, Opportunities and Forecast To 2022

AXA Insurance Market Research Report 2018 Analysis and Forecast to 2022

PUNE, INDIA, March 30, 2018 /EINPresswire.com/ — Summary
"Insurance Company Profile: AXA", offers a review of the company, its business structure and strategy, its financial performance, its marketing and distribution activities, and a SWOT analysis.

AXA Group is one of the largest financial services providers in the world. France is AXA's largest insurance market, followed by the US, the UK, and Ireland. It operates in four business segments: life and savings, property and casualty, asset management, and banking. It has a presence in 64 countries, serves over 107 million customers across the world, and has around 165,000 employees and agents.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/2575110-insurance-company-profile-axa

Companies mentioned
AXA
AXA PPP Healthcare
AXA Strategic Ventures
Kamet
Swiftcover

Key Questions Answered
– What are AXA’s brands?
– What are AXA’s strengths and weaknesses?
– What opportunities and challenges does the company face going forward?

Scope
– AXA introduced its new strategic five-year plan, Ambition 2020, on June 21, 2016 following the completion of its Ambition 2015 plan. The new plan is focused on two themes: focus and transform.
– In May 2017 AXA launched a new business unit dedicated to customer innovation and new business models to support its 2020 strategy.
– The unit will consolidate AXA’s plans aimed at expanding the value chain of insurance services by utilizing new technologies and the group’s innovation initiatives.

AXA is the world's second-largest financial services company by revenue ($147.5 B). (Wikipedia)

Reasons to buy
– Learn about AXA’s organizational structure and its core business segments.
– Gain insight into its underwriting and distribution strategy
– Understand the group's advertising strategy.

Table of Content: Key Points
Operations
AXA: A Global Overview
Corporate Structure
Historic Milestones
What Does AXA Do Today?
AXA Product Overview

Strategy
Future Strategy
Partnerships
Advertising Expenditure

SWOT Analysis
Strengths
Weaknesses
Opportunities
Threats
…Continued

ACCESS REPORT @ https://www.wiseguyreports.com/reports/2575110-insurance-company-profile-axa

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Cards and Payments Thailand Market 2018 – Entry Exit of Key Players, Identify Opportunities and Challenges

Cards and Payments Thailand Market 2017 – Opportunity, Driving Trends and deep study.

PUNE, INDIA, March 30, 2018 /EINPresswire.com/ — Summary
"The Cards and Payments Industry in Thailand: Emerging Trends and Opportunities to 2021" report provides detailed analysis of market trends in the Thai cards and payments industry. It provides values and volumes for a number of key performance indicators in the industry, including credit transfers, direct debits, check payments, payment cards and cash transactions during the review period (2012-2016).

The report also analyzes various payment card markets operating in the industry, and provides detailed information on the number of cards in circulation, transaction values and volumes during the review period and over the forecast period (2017-2021). It also offers information on the country's competitive landscape, including the market shares of issuers and schemes.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/1015976-the-cards-and-payments-industry-in-thailand-emerging-trends-and-opportunities

The report brings together research, modeling, and analysis expertise to allow banks and card issuers to identify segment dynamics and competitive advantages. The report also covers details of regulatory policy and recent changes in the regulatory structure.

Companies mentioned
Bangkok Bank
Kasikorn Bank
Krungthai Bank
Siam Commercial Bank
TMB Bank
Krungsri Bank
Aeon Credit Service
Visa
Mastercard
American Express
Diners Club

The report provides top-level market analysis, information and insights into the Thai cards and payments industry, including –
– Current and forecast values for each market in the Thai cards and payments industry, including debit, credit and charge cards.
– Detailed insights into payment instruments including credit transfers, direct debits, cash transactions, checks and payment cards. It also, includes an overview of the country's key alternative payment instruments.
– E-commerce market analysis and payment methods.
– Analysis of various market drivers and regulations governing the Thai cards and payments industry.
– Detailed analysis of strategies adopted by banks and other institutions to market debit, credit and charge cards.
– Comprehensive analysis of consumer attitudes and buying preferences for cards.
– The competitive landscape in the Thai cards and payments industry.

Scope
– As part of the government’s Payment Systems Roadmap 2012-2016, the Bank of Thailand and Thai Bankers’ Association developed a national e-payment system, Prompt Pay, in 2016. This system was launched in January 2017, and is to be deployed in two phases. In the first phase, users are required to link their bank accounts with a mobile number or national ID number – thereby transferring money to recipients or making payments at merchants without the need to divulge bank account details – while phase two allows users to conduct other transactions such as bill payment and request-to-pay services.
– In order to develop the country’s financial sector and promote electronic payments, the Thai government launched the Financial Sector Master Plan (FSMP III) in March 2016; this was an extension to the previously launched FSMP I and II. The plan fosters the government, business and retail sectors to create an environment and infrastructure conducive to the adoption of electronic and financial payments. Some of the initiatives in this regard include the development of robust payment infrastructure, financial literacy among consumers, efficient pricing mechanisms, the establishment of an integrated IT system and industry-wide shared infrastructure and fraud monetary systems. Initiatives like these are expected to further boost electronic payments in the country.
– Mobile network operators (MNOs) are also contributing to the promotion of electronic payments. Leading MNOs, including Advanced Info Services (AIS), Total Access Communication Company (DTAC) and True Move H, are now all offering their own digital wallets. To further increase the use of wallets among their subscribers, in 2015 the three MNOs collaborated to integrate their respective wallets – mPAY, Jaew Wallet and True Money – allowing subscribers to make person-to-person (P2P) payments across the three mobile networks using recipients’ mobile numbers.

Reasons to buy
– Make strategic business decisions, using top-level historic and forecast market data, related to the Thai cards and payments industry and each market within it.
– Understand the key market trends and growth opportunities in the Thai cards and payments industry.
– Assess the competitive dynamics in the Thai cards and payments industry.
– Gain insights into marketing strategies used for various card types in Thailand.
– Gain insights into key regulations governing the Thai cards and payments industry.

Table of Content: Key Points
EXECUTIVE SUMMARY
1.1. Market overview
1.2. Key facts
1.3. Top five industry events
2 PAYMENT INSTRUMENTS
2.1. Current payment environment
3 E-COMMERCE AND ALTERNATIVE PAYMENTS
3.1. E-Commerce market analysis
3.2. Alternative payment solutions
3.2.1. PayPal
3.2.2. Prompt Pay
3.2.3. mPay
3.2.4. True Money
3.2.5. Master Pass
3.2.6. Line Pay
3.2.7. AirPay
3.2.8. Fortumo
3.2.9. 123 Payment
4 REGULATIONS IN THE CARDS AND PAYMENTS INDUSTRY
4.1. Regulatory framework
4.2. Anti-money laundering and counter terrorism financing (AML/CTF)
4.3. Foreign direct investment (FDI) regulations
5 ANALYSIS OF CARDS AND PAYMENTS INDUSTRY DRIVERS
6 PAYMENT CARDS
7 DEBIT CARDS
7.1. Debit cards market analysis
7.2. Competition in debit cards market
7.3. Debit cards comparison
8 PAY LATER CARDS
8.1. Pay later cards market analysis
8.2. Competition in pay later cards market
…Continued

ACCESS REPORT @ https://www.wiseguyreports.com/reports/1015976-the-cards-and-payments-industry-in-thailand-emerging-trends-and-opportunities

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

UK SME Insurance Market 2017: Key Players AXA, Aviva, Allianz, LV=, RSA, NFU Mutual, Lloyds

UK SME Insurance Industry 2017- By Plan Future Business Decisions Using the Forecast Figures

PUNE, INDIA, March 30, 2018 /EINPresswire.com/ — Summary
"UK SME Insurance: Competitor Dynamics 2017", looks at which insurers lead the way in the SME segment and how they are developing their propositions, as well as highlighting how competitor positions vary between micro, small, and medium enterprises. It examines which insurers are winning over brokers and which companies SMEs are placing their business with.

AXA and Aviva dominate the SME insurance space across the vast majority of the 16 commercial products listed in our 2017 UK SME Insurance Survey. Other insurers present in the market play to their strengths when servicing SMEs. Hiscox and Zurich are popular providers for liability products, while Allianz and Direct Line are strong in commercial motor. The main story from the 2017 results is of AXA’s lead narrowing. While Aviva’s share also fell, the margin in market shares between the two has reduced in the vast majority of the nine lines that AXA and Aviva place first and second respectively.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/2456959-uk-sme-insurance-competitor-dynamics-2017

Scope
– AXA and Aviva lead the SME insurance space, with 13.9% and 11.3% of SMEs respectively holding a commercial insurance policy with these providers.
– AXA remains dominant across the 16 product lines, but Aviva is closing the gap.
– Brokers place the most SME business with Allianz, Aviva, and AXA.

Companies mentioned
AXA
Aviva
Allianz
Direct Line
Zurich
Hiscox
RSA
NFU Mutual
Lloyds
Travelers
LV=
AA

Reasons to buy
– Benchmark yourself against the rest of the market.
– Ensure you remain competitive as new innovations and insurance models begin to enter the market.
– Adapt your distribution strategy to ensure it is efficient and still meets customer purchasing behavior.

Table of Content: Key Points
1. EXECUTIVE SUMMARY 2
1.1. AXA and Aviva continue to lead the market 2
1.2. Key findings 2
1.3. Critical success factors 2
2. THE SME MARKET AND ITS LEADING COMPETITORS 7
2.1. Introduction 7
2.2. Allianz and Aviva continue to lead the way for brokers 7
2.3. Aviva’s dominance in non-packaged insurance has been challenged 9
2.4. The increasing focus on cybercrime is an opportunity for insurers 11
2.4.1. Some insurers are looking to innovate to gain an edge in a tough market 11
2.5. The key players 12
2.5.1. AXA is looking into its commercial motor offering 12
2.5.2. Aviva revamps cyber cover 13
2.5.3. Allianz focuses on Brexit 13
2.5.4. Hiscox embraces technology 13
2.5.5. Zurich targets education 13
2.6. Technology is emerging in the market 14
2.6.1. New entrants are rare, but the Financial Conduct Authority sandbox is showing promise 15
3. PRODUCT POSITIONING 16
3.1. AXA is the dominant insurer, but Aviva is closing the gap 16
3.1.1. Aviva performs well in commercial motor lines, while Allianz is popular with larger SMEs 17
3.1.2. Hiscox is popular in non-motor lines 18
3.1.3. Direct Line remains strong in motor lines 19
3.1.4. NFU Mutual is strong in niche commercial motor lines 19
4. NPS 37
4.1. Hiscox has the edge in customer satisfaction 37
…Continued

ACCESS REPORT @ https://www.wiseguyreports.com/reports/2456959-uk-sme-insurance-competitor-dynamics-2017

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

JAY SUITES LEASES HUDSON’S BAY COMPANY’S US HEADQUARTERS AT 15 WEST 38TH STREET

Jay Suites Logo

15 West 38th Street

Adding our 8th

150 Offices, 1000 Members, Amenities, Cafe, Conferences, Roof Deck....

Jay Suites Newest Location 15 West 38th Street

8th Manhattan Location to Offer 150 Co-Working Offices, Conference Center, Rooftop, Café and Amenity Floor

NEW YORK, NY, UNITED STATES, March 30, 2018 /EINPresswire.com/ — Jay Suites announced today that it has signed a 17-year, triple net lease for the entire 12-floor building at 15 West 38th Street that served as headquarters for Hudson’s Bay Company, owner of Lord & Taylor, Saks Fifth Avenue and Gilt Groupe. The 90,000-square-foot building expands Jay Suites portfolio to 8 properties and more than 5,000 workstations and will include a signature 22,000 square foot Jay Conference center on the retail 2nd and 3rd floors, Jay Café on the ground level, a rooftop terrace, as well as Jay Suites offices and workspaces on 7 floors. Jay Suites was founded in 2009 with a vision to offer affordable, spacious, sophisticated work environment for maximum productivity. The location is expected to open in Summer of 2018.

“We have been waiting opportunistically and for quite some time to expand our presence in the heart of midtown in an operationally efficient way. This deal – with its below market rent, location and footprint – will let Jay Suites offer its core private luxury office spaces with a full suite of amenities as well as flexible larger team and conference rooms to NYC companies for excellent value. The deal also benefits Hudson’s Bay Company as its need for underutilized space shifts,” said Jack Srour, Co-Founder and COO of Jay Suites

The 12-story, Baroque red terra cotta building, located on 38th and still connected by a bridge to Lord & Taylor’s Fifth Avenue store, was built in 1909. The space was previously occupied by Hudson’s Bay Company as its former U.S. headquarters. Situated on one of midtown Manhattan’s premier, historic, retail and corporate corridors, the building offers premium accessibility to urban city dwellers and professionals. The area features a richly varied mix of restaurants, service businesses and numerous apparel and accessory retailers.

Juda Srour, Co-Founder and President of Jay Suites, added “This project is a game changer for Jay Suites. It is our largest project to date and fulfills our dream to house one of our locations in a full building in midtown Manhattan, right in the middle of our 7 other midtown locations which are already over 90 percent occupied. Importantly, this new location will be our first to offer all four signature Jay Suites venues under one umbrella.”

Jay Suites plans to deploy $10 Million to renovate, upgrade, and modernize the technology, infrastructure, work and conference space, rooftop and retail in the 12-story building located between 37th & 38th Streets, adjacent to Lord & Taylor’s landmark building that WeWork purchased in October 2017. Its proximity offers prospective and existing tenants complementary but distinctive shared office space and amenities.

More companies and entrepreneurs are relying on flexible, furnished office space like Jay Suites that invest resources and expertise efficiently and provide excellent value for a differentiated offering. The large block of space at the new location expands Jay Suites ability to compete with industry leaders like IWG (Regus) and WeWork, valued currently at $4 billion and $20 billion, respectively, due to the growing demand for shared office product and opportunistic real estate.

Sean Black of BLACKre represented Jay Suites. Laura Pomerantz and Maria Travlos of Cushman & Wakefield represented Hudson’s Bay Company, the sublandlord. The Rosen Group owns the building.

Jay Suites will relocate its headquarters to the new location.

About Jay Suites (www.jaysuites.com)
Jay Suites is a privately-owned developer, owner and manager of shared office work space in Manhattan and among the top three shared office companies in New York City after WeWork and Regus. Founded in 2009 and headquartered in New York City, Jay Suites offers 8 locations, over 5,000 desks, two rooftop terraces, conference rooms and a suite of amenities.

Jay Suites is a hub for New York City entrepreneurs looking to simply work better. The concept offers flexible, luxury office suites, virtual office plans and on-demand conference rooms. All Jay Suites offices are furnished, elegantly designed and come equipped with state-of-the-art technology, resources and support. Members belong to a growing community with perks such as exclusive access to members-only meet ups. With locations throughout midtown and downtown New York City, Jay Suites offers the best of operational efficiency and premier luxury office suite packages, customized serviced office space solutions and common areas with fixed, all-inclusive pricing and flexible terms. Jay Suites spaces are replete with modern décor and amenities, state of the art technology, infrastructure, security, accessibility and business and maintenance services.

Kimberly Macleod
kmacconnect pr
917-587-0069
email us here


Source: EIN Presswire

REAL TRENDS 500 REPORT RANKS NATION'S LARGEST REAL ESTATE FIRMS

Rudy Lira Kusuma the #1 Real Estate Team Leader in California

Rudy Lira Kusuma Home selling team endorsed by local homeowners

Rudy L Kusuma sold local home in Arcadia for more money

Rudy L. Kusuma Home Selling Team

Rudy L. Kusuma Home Selling Team Ranked #1 The Most Reviews and Endorsements from Local Home Owners in zillow – Southern California Real Estate Market

Rudy Lira Kusuma Home Selling Team Recognized as one of the nation's Leading Residential Real Estate Companies

In addition to the ranking of the top 500 firms, REAL Trends recognizes the industry’s Up-and-Comers. Included in the Up-and-Comers is Rudy Lira Kusuma Home Selling Team. ”

— 2018 REALTRENDS

SAN GABRIEL, CA, 91770, March 29, 2018 /EINPresswire.com/ — REAL Trends, the trusted source for news and research about the real estate brokerage industry, announced the results of the 2018 REAL Trends 500, an independently verified compilation of the nation’s leading residential real estate companies.

In addition to the ranking of the top 500 firms, REAL Trends recognizes the industry’s Up-and-Comers. While these firms didn’t close the minimum 1,899 residential transaction sides required to make the top 500, they closed a minimum of 500 sides which still puts them among the industry’s elite.

Included in the Up-and-Comers is RE/MAX TITANIUM – TEAM NUVISION – RUDY LIRA KUSUMA HOME SELLING TEAM headquartered in San Gabriel Valley, greater Los Angeles area. RE/MAX TITANIUM – TEAM NUVISION closed 556 in 2017, ranking it as one of the top firms in the California region.

This year's survey represents the most comprehensive collection of data assembled on the leaders of the residential brokerage industry. Numbers are documented by outside accounting firms.

To view the rankings, go to https://www.realtrends.com/rankings/rt500. This year, REAL Trends is offering the REAL Trends 500 information for free!

About REAL Trends: REAL Trends has been The Trusted Source for news, analysis and information about the residential real estate industry since 1987. We are a privately-held publishing, communications and consulting company based in Castle Pines, Colorado. Residential real estate leaders find timely and trusted information and analysis through our yearly event—Gathering of Eagles—our monthly newsletter and other publications.

About RE/MAX TITANIUM – TEAM NUVISION – RUDY LIRA KUSUMA HOME SELLING TEAM:

YOUR HOME SOLD GUARANTEED OR I'LL BUY IT*
To discuss the sale of your home, call Rudy at 626-789-0159 and start packing!

6 BIG REASONS TO CALL OUR TEAM TO SELL YOUR HOME:

1.) WE HAVE BUYERS IN WAITING
We have 25,127 buyers in our database looking for a home in the area. It is likely that the buyer for your home is already in my database – Your home may already be sold!

2.) YOUR HOME WILL SELL FOR $12,000 MORE*
We sell our clients homes for an average of 3.1% more money compared to the average area agent. On a $400,000 home, that's an extra $12,400 more money in your pocket.

3.) YOUR HOME WILL SELL 3 TIMES FASTER
We sell our clients homes on average in only 29 days while the average area agent sells theirs in 87.9 days.

4.) WE SELL MORE HOMES
In fact, we sell over 20x more homes than your average agent. Because we sell so many more homes than our competitors, financially there are extra things we can do for you that other real estate agents and brokers don't offer: Your home will get far more exposure, Your home will be exposed to buyers in a much larger area nationally and internationally, Your home will sell fast and for top dollars because of our unique and exclusive consumer programs.

5.) YOUR HOME IS MORE LIKELY TO SELL
Not only do we sell our clients homes for more money and faster than average area agent, your home is more likely to sell. According to 2015 MLS statistics, only 71% of area homes sold during their listing term. Compare that to our 97% of homes listed that sold before the end of the listing term.

6) PROVEN EXPERIENCE… PROVEN RESULTS
Yes it is important to verify the professional abilities of an agent before you hire one to help you sell or buy a home.
The only way to guarantee expertise is to hear directly from people who have had personal experience with the agent.
Read what other local home owners have to say about our team – https://www.zillow.com/profile/rudylk/

YOUR HOME SOLD GUARANTEED OR I'LL BUY IT*
To discuss the sale of your home, call Rudy at 626-789-0159 and start packing!

California Real Estate Broker License 01820322

RUDY L KUSUMA
RE/MAX TITANIUM – TEAM NUVISION – Rudy L Kusuma Home Selling
6267890159
email us here


Source: EIN Presswire

SystemDomain, Chicago based IT firm Signs Strategic Partnership with Ostendio, global leader in Cyber Security solutions

SystemDomain, Inc has enhanced its Cyber Security and Risk Management product portfolio by partnering with Ostendio, to deliver information security compliance.

CHICAGO, IL, USA, March 29, 2018 /EINPresswire.com/ — SystemDomain, Inc., a leading global information technology consulting services company, today announced that it has signed a strategic partnership with Ostendio, a provider of an award winning cyber security platform for compliance and information management.

“SystemDomain now offers its customers a complete solution to make an enterprise more secure and protect business-critical data and applications by offering an industry leading cyber security compliance and information management platform that delivers an easy to use, cost-effective way for companies to demonstrate information security compliance to multiple industry standards and regulations,” said Shubhi Garg, Managing Partner, SystemDomain, Inc. “This will enhance SystemDomain's product portfolio in our Cyber Security business unit".

“We’re excited to partner with SystemDomain as we focus our combined energies to serve a broader range of customers with industry-leading cyber security and risk management solutions”, said Grant Elliott, Ostendio President and CEO. “Ostendio will leverage SystemDomain’s client portfolio and leading IT professional services capabilities to implement and integrate its portfolio of products across various industry segments".

SystemDomain had been ranked as:
• Top 20 Most Promising Cyber Security Solution Provider 2017' by “Silicon India”
• DiversityBusiness.com’s (now OMNIKAL) OMNI500 Top Businesses for 2017
• Gold Medal as the Fastest Growing Cyber Security Firm by Cyber Security Excellence Awards

About SYSTEMDOMAIN, INC.
SystemDomain is global information technology and consulting services company based in Chicago, IL with focus in Cyber Security & Risk Management, Digital, Cloud, Data Analytics and Professional Services (such as Enterprise Architecture, Database, Network Management, ERP, CRM, Cloud and Digital Transformation). SystemDomain strives to connect with their customers, clients, and partners with an unbeatable portfolio of solutions to leverage critical trends such as big data & analytics, social business and security. SDI has offshore software development and support centers for clients who are interested in cost-effective and reliable services. World's leading software companies had signed partnership with SystemDomain to integrate and implement their solutions across various industries.
For more information, please visit www.systemdomaininc.com

About Ostendio
Ostendio’s MyVCM™ streamlines the way companies build, manage and demonstrate their information security framework. The MyVCM platform provides an enterprise view of an organization’s cybersecurity program. MyVCM’s unique bottom-up security approach provides a workflow solution which engages every employee and manages all aspects of security and compliance which allows organizations to easily report their security posture to internal and external stake-holders. With MyVCM, customers can ensure they are secure and compliant.
Ostendio is headquartered in Arlington, VA and has customers in North America, Europe, the Middle East and Australia.
For more information about Ostendio’s MyVCM, please visit www.ostendio.com and follow us on Twitter, and LinkedIn.

For More Information

Media Relations
SystemDomain Inc
+1 (630) 544 4180
email us here


Source: EIN Presswire